Unitedhealth Group Stock Earnings Reports

UnitedHealth Group reported a solid start to 2026 with all operating segments beating plan in Q1. Adjusted EPS was $7.23, above expectations, and management raised its full-year view to greater than $18.25 per share while reiterating a front‑loaded earnings cadence (about two‑thirds in H1). Revenues were $111.7 billion and membership totaled 49.1 million. Medical care ratio improved to 83.9% (vs. 84.8% a year ago), helped by pricing discipline, reserve development and early operational improvements. Optum Health delivered stronger‑than‑expected adjusted earnings ($1.3 billion) driven by clinical and operational fixes and prior year development; management expects Optum Health margins to normalize through 2026 into 2027 with a long‑term sustainable margin target of roughly 6%–8%. Optum Insight is gaining traction with AI‑first products and Optum Rx onboarded 800+ clients while expanding digital/AI self‑service. The company plans to invest nearly $1.5 billion in AI initiatives in 2026 aimed at both internal automation and commercial AI products. Management is focused on margin recovery and product stability (including more disciplined pricing in Medicare and commercial), expects ACA membership to decline roughly one‑third in 2026, and continues to press states for Medicaid rate alignment. Capital allocation priorities are: invest in growth, strengthen the balance sheet (debt/capital down to 42.9%, target ~40% year‑end), and return capital — at least $2 billion of share repurchases expected by end of Q2. Key operational priorities highlighted: continued reduction and digitization of prior authorizations, expansion of value‑based care, rural provider support, and commercialization of AI/Optum Insight capabilities. Management emphasized prudence in AI rollout and the multi‑quarter nature of visibility (Q2 will be informative for trends).